tiprankstipranks
Advertisement
Advertisement
Lexeo Therapeutics Announces Key Executive Leadership Changes
PremiumCompany AnnouncementsLexeo Therapeutics Announces Key Executive Leadership Changes
2M ago
Lexeo appoints Narinder Bhalla as CMO, Eric Adler as CEO, Myoventive
Premium
The Fly
Lexeo appoints Narinder Bhalla as CMO, Eric Adler as CEO, Myoventive
2M ago
Lexeo appoints Jose Manuel Otero as COO
Premium
The Fly
Lexeo appoints Jose Manuel Otero as COO
2M ago
Lexeo announces preliminary data from HEROIC-PKP2 Phase I/II trial
PremiumThe FlyLexeo announces preliminary data from HEROIC-PKP2 Phase I/II trial
3M ago
Lexeo Therapeutics announces research collab with Johnson & Johnson
Premium
The Fly
Lexeo Therapeutics announces research collab with Johnson & Johnson
3M ago
Raymond James Sees an Attractive Setup in These 2 ‘Strong Buy’ Stocks
Premium
Stock Analysis & Ideas
Raymond James Sees an Attractive Setup in These 2 ‘Strong Buy’ Stocks
4M ago
Optimistic Buy Rating for Lexeo Therapeutics Driven by High-Dose Potential and Superior Safety Profile
PremiumRatingsOptimistic Buy Rating for Lexeo Therapeutics Driven by High-Dose Potential and Superior Safety Profile
5M ago
Lexeo Therapeutics Reports Decreased Losses and Strong Cash Position
Premium
Company Announcements
Lexeo Therapeutics Reports Decreased Losses and Strong Cash Position
5M ago
Lexeo Therapeutics files to sell 1.25M shares of common stock for holders
Premium
The Fly
Lexeo Therapeutics files to sell 1.25M shares of common stock for holders
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100